CapsCanada – Markets
Markets
Innovator Pharmaceuticals
The drug innovation market continues to evolve to the demands of modern healthcare and global populations, with higher value, smaller volume therapies being developed to tackle cancers, cardiovascular problems, and autoimmune disorders – among a growing range of niche therapies and orphan drugs.
At CapsCanada, we understand the compounds pharma and biotech companies are seeking to develop are increasingly complex, and the role we can play in making formulations stable in oral dosage forms.
Markets

At CapsCanada, we understand the compounds pharma and biotech companies are seeking to develop are increasingly complex, and the role we can play in making formulations work in oral dosage forms. Many companies are developing potent drugs, and many new compounds face bioavailability challenges due to low solubility, which can be difficult to overcome in oral dosage forms.

Our experience working with pharmaceutical companies for over 30 years and continually innovating capsule technologies provides a foundation of engineering expertise that complements our customers’ scientific knowledge, which overcomes obstacles and makes challenging formulations work in capsule form.

With our top-quality K-CAPS® HPMC capsules and vertically integrated gelatin supply chain, CapsCanada is a natural choice for the quality, reliability and expertise that pharmaceutical innovators need to develop viable products for global patient populations.